Monthly investor meeting on the 25th of September

September 23, 2025

Hamlet BioPharma invites you to our September investors’ meeting to be held on the 25th of September 2025, at 12:00.

Please click on the link below to participate in the meeting

For further information, please contact:

Catharina Svanborg, CEO and Founder of Hamlet BioPharma, +46-709 42 65 49

Jakob Testad, CFO, Hamlet BioPharma AB, +46 708 48 42 10

January 16, 2026

December 18, 2025

December 4, 2025

November 14, 2025

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.

Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958

Subscribe to receive
Pressreleases and Newsletters

Hamlet BioPharma.